Business ❯ Pharmaceutical Industry ❯ Regulatory Affairs

FDA

Therapeutics Biologics License Application Drug Review Process Sarepta Therapeutics Orphan Drug Designation Corporate Governance

Former FDA Biologics Chief Peter Marks Joins Eli Lilly to Lead Infectious Disease and Molecule Discovery

The move, six months after his clash with HHS Secretary Robert F. Kennedy Jr., has revived scrutiny of the regulator-to-industry pipeline.

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data